2018
DOI: 10.1186/s13054-018-2115-9
|View full text |Cite
|
Sign up to set email alerts
|

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…We recently proposed higher vit C dosing in cardiac arrest patients who require continuous renal replacement therapy (CRRT). [1] In a reaction, Spoelstra-de Man et al . rebutted that increasing the vit C dose above 2 g/day during continuous veno-venous hemofiltration (CVVH) was unnecessary when normal plasma vit C concentrations are targeted.…”
Section: To the Editormentioning
confidence: 99%
“…We recently proposed higher vit C dosing in cardiac arrest patients who require continuous renal replacement therapy (CRRT). [1] In a reaction, Spoelstra-de Man et al . rebutted that increasing the vit C dose above 2 g/day during continuous veno-venous hemofiltration (CVVH) was unnecessary when normal plasma vit C concentrations are targeted.…”
Section: To the Editormentioning
confidence: 99%
“…17 Some recommendations suggest avoiding supplementing >250 mg/ day to reduce the risk of nephrotoxic oxalate deposition in the kidneys, 9 whereas others contend that higher doses of supplementation are required to overcome the net negative balances induced by CRRT. 17 The European Society for Clinical Nutrition and Metabolism (ESPEN) clinical practice guidelines comment that patients receiving CRRT may develop severe micronutrient deficiencies and that vitamin C status should be monitored and supplemented based on serum levels and effluent losses, although they do not comment on specific dosage recommendations. 11,18 A patient developed a severe vitamin C deficiency after receiving prolonged CRRT despite receiving ascorbic acid supplementation of 450 mg/day in her parenteral nutrition (PN).…”
Section: Introductionmentioning
confidence: 99%
“…Significant vit C deficiency was observed in 80% of patients subjected to various types of CRRT despite receiving a daily intravenous (IV) supplement of 500 to 1000 mg [2]. Therefore, high-dose (from 6 to 12 g) vit C substitution during CRRT seems justified [3].…”
mentioning
confidence: 99%